Private Advisor Group LLC Has $9.86 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Private Advisor Group LLC decreased its holdings in CVS Health Co. (NYSE:CVS) by 5.9% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 123,667 shares of the pharmacy operator’s stock after selling 7,767 shares during the quarter. Private Advisor Group LLC’s holdings in CVS Health were worth $9,864,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. SOA Wealth Advisors LLC. lifted its holdings in shares of CVS Health by 4.9% during the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock valued at $226,000 after purchasing an additional 133 shares during the last quarter. Apella Capital LLC boosted its holdings in CVS Health by 4.2% in the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock worth $272,000 after acquiring an additional 136 shares in the last quarter. Prairie Sky Financial Group LLC grew its stake in shares of CVS Health by 4.1% during the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock worth $285,000 after acquiring an additional 141 shares during the last quarter. WealthShield Partners LLC increased its holdings in shares of CVS Health by 3.2% during the fourth quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock valued at $355,000 after acquiring an additional 141 shares in the last quarter. Finally, Sugarloaf Wealth Management LLC boosted its stake in CVS Health by 9.5% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock worth $129,000 after purchasing an additional 142 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Activity at CVS Health

In related news, Director Edward J. Ludwig bought 1,000 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was bought at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the acquisition, the director now directly owns 21,630 shares in the company, valued at $1,165,424.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.24% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CVS shares. SVB Leerink reaffirmed a “market perform” rating and issued a $60.00 price target (down previously from $87.00) on shares of CVS Health in a report on Wednesday, May 1st. Baird R W raised CVS Health to a “hold” rating in a report on Thursday, May 30th. The Goldman Sachs Group decreased their target price on CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. JPMorgan Chase & Co. cut their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Finally, Wells Fargo & Company dropped their price objective on shares of CVS Health from $76.00 to $60.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 7th. Eleven equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $75.05.

CVS Health Price Performance

CVS Health stock traded down $0.08 during midday trading on Friday, reaching $56.62. The company had a trading volume of 6,095,532 shares, compared to its average volume of 11,936,229. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The firm’s fifty day simple moving average is $58.68 and its 200-day simple moving average is $69.71. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. The company has a market capitalization of $71.08 billion, a P/E ratio of 9.92, a P/E/G ratio of 0.54 and a beta of 0.52.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing the consensus estimate of $1.69 by ($0.38). The firm had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the prior year, the company posted $2.20 earnings per share. As a group, equities analysts anticipate that CVS Health Co. will post 7.02 EPS for the current year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.